BR0112386A - Sistema e métodos para tratar uma superfìcie mucosal - Google Patents

Sistema e métodos para tratar uma superfìcie mucosal

Info

Publication number
BR0112386A
BR0112386A BR0112386-6A BR0112386A BR0112386A BR 0112386 A BR0112386 A BR 0112386A BR 0112386 A BR0112386 A BR 0112386A BR 0112386 A BR0112386 A BR 0112386A
Authority
BR
Brazil
Prior art keywords
amines
mucosal surface
mri
treating
methods
Prior art date
Application number
BR0112386-6A
Other languages
English (en)
Inventor
John C Hedenstrom
Michael J Jozwiakowski
Mark M Martinez
Kenneth R Phares
Kenneth F Trofatter Jr
Original Assignee
3M Innovative Properies Compan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/676,339 external-priority patent/US6486168B1/en
Application filed by 3M Innovative Properies Compan filed Critical 3M Innovative Properies Compan
Publication of BR0112386A publication Critical patent/BR0112386A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4748—Quinolines; Isoquinolines forming part of bridged ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Reproductive Health (AREA)
  • Oncology (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"SISTEMAS E MéTODOS PARA TRATAR UMA SUPERFìCIE MUCOSAL". Um sistema para tratar uma condição associada com uma superfície mucosal, o sistema compreendendo um composto modificador de resposta imunológica (IRM) escolhido a partir de aminas de imidazoquinolina, aminas de imidazopiridina, aminas de cicloalquilimidazopiridina 6,7-fundidas, aminas de imidazonaftiridina, aminas de oxazoloquinolina, aminas de tiazoloquinolina, aminas de imidazoquinolina 1,2-ligados por ponte, e sais farmaceuticamente aceitáveis disso e um dispositivo aplicador para aplicar o composto IRM à superfície mucosal. O sistema de compostos IRM e aplicador pode ser usado para tratar condições associadas com superfícies mucosais tais como displasia do colo do útero e neopiasia intraepitelial do colo do útero.
BR0112386-6A 2000-06-22 2001-06-22 Sistema e métodos para tratar uma superfìcie mucosal BR0112386A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21342000P 2000-06-22 2000-06-22
US09/676,339 US6486168B1 (en) 1999-01-08 2000-09-29 Formulations and methods for treatment of mucosal associated conditions with an immune response modifier
PCT/US2001/019979 WO2001097795A2 (en) 2000-06-22 2001-06-22 Systems and methods for treating a mucosal surface

Publications (1)

Publication Number Publication Date
BR0112386A true BR0112386A (pt) 2003-06-10

Family

ID=26908067

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0112386-6A BR0112386A (pt) 2000-06-22 2001-06-22 Sistema e métodos para tratar uma superfìcie mucosal

Country Status (17)

Country Link
EP (1) EP1296644A2 (pt)
JP (1) JP2004508851A (pt)
CN (1) CN1273110C (pt)
AU (1) AU2001270081A1 (pt)
BR (1) BR0112386A (pt)
CA (1) CA2410208A1 (pt)
CZ (1) CZ20024175A3 (pt)
EE (1) EE200200705A (pt)
HR (1) HRP20021024A2 (pt)
HU (1) HUP0301233A2 (pt)
IL (1) IL153087A0 (pt)
MX (1) MXPA02012524A (pt)
NO (1) NO20026067L (pt)
NZ (1) NZ523073A (pt)
PL (1) PL361975A1 (pt)
SK (1) SK17812002A3 (pt)
WO (1) WO2001097795A2 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0211649D0 (en) 2002-05-21 2002-07-03 Novartis Ag Organic compounds
US20060247190A1 (en) 2002-10-21 2006-11-02 Kathleen Beach Compositions and methods for treating human papillomavirus mediated disease
WO2005041847A2 (en) * 2003-10-22 2005-05-12 University Hospitals Of Cleveland Method and apparatus for applying medication to internal tissue
US9248127B2 (en) 2005-02-04 2016-02-02 3M Innovative Properties Company Aqueous gel formulations containing immune response modifiers

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5939090A (en) * 1996-12-03 1999-08-17 3M Innovative Properties Company Gel formulations for topical drug delivery
CZ20012446A3 (cs) * 1999-01-08 2002-01-16 3M Innovative Properties Company Farmaceutický prostředek pro léčbu onemocnění sliznice

Also Published As

Publication number Publication date
WO2001097795A2 (en) 2001-12-27
SK17812002A3 (sk) 2003-05-02
AU2001270081A1 (en) 2002-01-02
EP1296644A2 (en) 2003-04-02
CZ20024175A3 (cs) 2003-06-18
PL361975A1 (en) 2004-10-18
JP2004508851A (ja) 2004-03-25
EE200200705A (et) 2004-08-16
CA2410208A1 (en) 2001-12-27
NO20026067L (no) 2003-02-17
HUP0301233A2 (hu) 2003-08-28
IL153087A0 (en) 2003-06-24
NZ523073A (en) 2005-04-29
CN1273110C (zh) 2006-09-06
MXPA02012524A (es) 2003-04-10
CN1437463A (zh) 2003-08-20
WO2001097795A3 (en) 2002-04-04
NO20026067D0 (no) 2002-12-17
HRP20021024A2 (en) 2005-02-28

Similar Documents

Publication Publication Date Title
NO20013230D0 (no) Formuleringer og fremgangsmåter til behandling av slimhinneassosierte tilstander med et immunresponsmodifiserendemiddel
EP1495758A3 (en) Formulations and methods for treatment of mucosal associated conditions with an immune response modifier
JP2007504145A5 (pt)
JP2006517974A5 (pt)
BRPI0411924A (pt) métodos e dispositivos para oclusão de lúmens de corpo e/ou para fornecimento de agentes terapêuticos
IS5181A (is) Salt af naftýridín karboxýlsýru afleiðu
BRPI0519797A (pt) método para a preparação de 2-metil-1-(2-metilpropil)-1h-imidazo [4, 5-c] [1, 5] naftiridin-4-amina, método para a obtenção de n4-(2-metilpropil)-3-nitro [1, 5] naftiridin-4-amina e método para a obtenção de 2-metil-1-(2-metilpropil)-5-oxido-1h-imidazo [4, 5-c] [1, 5] naftiridina
WO2006084251A3 (en) Aqueous gel formulations containing immune reponse modifiers
GR3033869T3 (en) IMIDAZO 4,5-c]QUINOLINE AMINES
NO20020532D0 (no) Farmasöytiske preparater inneholdende beta-carbolin
TR200103302T2 (tr) Diamorfin etkin maddeli farmasötik preparat
IL161786A (en) Pharmaceutical formulation comprising an immune response modifier and hydrophobic aprotic component
BG106221A (en) Morphine-containing intranasal pharmaceutical preparations and methods for their administration
HUP0000450A2 (hu) 7-(2-Oxa-5,8-diazabiciklo[4.3.0]non-8-il)-kinolon-karbonsav és -naftiridon-karbonsav-származékok alkalmazása Helicobacter pylori fertőzések, és az ezzel kapcsolatos gyomor-bél megbetegedések gyógyítására szolgáló gyógyszerkészítmények előállítására
BR0112386A (pt) Sistema e métodos para tratar uma superfìcie mucosal
NO20044156L (no) Nye 1,2,3-substituerte indolizinderivater, inhibitorer av FGF`er, fremgangsmate for fremstilling av de samme, og farmasoytiske preparater inneholdende de samme
HK1033281A1 (en) Oral medicinal preparations with reproducible release of the active ingredient gatifloxacin or its pharmaceutically suitable salts or hydrates
BR0010728A (pt) Agentes antibacterianos de ácido quinolino e naftiridino carboxìlico
DE60011748D1 (de) Methoden und zusammenstellungen zur behandlung der weiblichen sexuellen dysfunktion
HUP0402358A2 (hu) Szelektív dopamin D4 receptor agonisták alkalmazása szexuális diszfunkciók kezelésére alkalmas gyógyszerkészítmény előállítására
ATE378335T1 (de) Chirale fluorochinolizinon arginine salze
GB0319037D0 (en) 7-Azaindole Derivatives
TR199901796A2 (xx) Kinolon ve naftiridon karboksilik asit haz�rlama usul�.
IT1315253B1 (it) Preparazione liposomiale di 6,9-bis-(2-amminoetil)ammino|benzog|isochinolin-5,10-dione dimaleato
MX2020005847A (es) Tratamiento del vsr con producto combinado.

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O, 11 E 13 DA LPI.

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.